On March 8, 2022 AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, reported that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the following three investor conferences in March (Press release, AngioDynamics, MAR 8, 2022, View Source [SID1234609713]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference: Oppenheimer Virtual Healthcare Conference
Date: Tuesday, March 15, 2022
Presentation: 8:40 a.m. ET

Conference: Barclays Global Healthcare Conference
Location: Miami Beach, FL
Date: Wednesday, March 16, 2022
Presentation: 9:00 a.m. ET

Conference: KeyBanc Virtual Life Sciences & MedTech Investor Forum
Date: Tuesday, March 22, 2022
Presentation: 3:45 p.m. ET

A live webcast of each presentation will be accessible through the "Investors" section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.